Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets

被引:1
|
作者
Vergara, Ismael A. [1 ,2 ,3 ]
Aivazian, Karina [1 ,4 ,5 ]
Carlino, Matteo S. [1 ,6 ,7 ]
Guminski, Alexander D. [1 ,8 ,9 ]
Maher, Nigel G. [1 ,2 ,4 ,5 ]
Shannon, Kerwin F. [1 ,2 ,10 ]
Ch'ng, Sydney [1 ,2 ,10 ]
Saw, Robyn P. M. [1 ,2 ,10 ]
Long, Georgina, V [1 ,2 ,3 ,8 ,9 ]
Wilmott, James S. [1 ,2 ,3 ]
Scolyer, Richard A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[3] Univ Sydney, Charles Perkin Ctr, Sydney, NSW, Australia
[4] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia
[5] NSW Hlth Pathol, Sydney, NSW, Australia
[6] Blacktown Hosp, Dept Med, Blacktown, NSW, Australia
[7] Westmead Hosp, Crown Princess Mary Canc Ctr, Dept Med, Sydney, NSW, Australia
[8] Royal North Shore, Sydney, NSW, Australia
[9] Mater Hosp, Sydney, NSW, Australia
[10] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
basal cell carcinoma; diagnosis; drivers; genomics; metastasis; pathology; therapeutic targets; treatment; COPY NUMBER; TUMOR; CANCER; PATHWAY; MUTATIONS; G691S; PHOSPHORYLATION; POLYMORPHISM; PROGRESSION; ACTIVATION;
D O I
10.1016/j.modpat.2023.100099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Basal cell carcinomas (BCCs) are human beings' most common malignant tumors. Most are easily managed by surgery or topical therapies, and metastasis is rare. Although BCCs can become locally advanced, metastatic BCCs are very uncommon and may be biologically distinct. We assessed the clinicopathologic characteristics of 17 patients with metastatic BCC and pursued whole-exome sequencing of tumor and germline DNA from 8 patients. Genomic profiling revealed aberrant acti-vation of Hedgehog signaling and alterations in GLI transcriptional regulators and Notch and Hippo signaling. Matched local recurrences of primary BCCs and metastases from 3 patients provided evi-dence of a clonal origin in all cases. Mutations associated with YAP inhibition were found exclusively in 2 hematogenously-spread lung metastases, and metastatic BCCs were enriched for mutations in the YAP/TAZ-binding domain of TEAD genes. Accordingly, YAP/TAZ nuclear localization was associated with metastatic types and Hippo mutations, suggesting an enhanced oncogenic role in hematogenously-spread metastases. Mutations in RET, HGF, and phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (AKT) signaling were enriched compared with a cohort of low clinical-risk BCCs. Our results implicate Hippo and PI3K/AKT dysregulation in metastatic progression of BCCs, making these potential therapeutic targets in metastatic disease. The common clonal origin of matched recurrent and metastatic BCCs suggests that molecular profiling can assist in determining the nature/origin of poorly differentiated metastatic tumors of uncertain type. Genes and pathways enriched for mutations in this cohort are candidate drivers of metastasis and can be used to identify patients at high risk of metastasis who may benefit from aggressive local treatment and careful clinical follow-up.(c) 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
    McDaniel, Andrew S.
    Hovelson, Daniel H.
    Cani, Andi K.
    Liu, Chia-Jen
    Zhai, Yali
    Zhang, Yajia
    Weizer, Alon Z.
    Mehra, Rohit
    Feng, Felix Y.
    Alva, Ajjai S.
    Morgan, Todd M.
    Montgomery, Jeffrey S.
    Siddiqui, Javed
    Sadis, Seth
    Bandla, Santhoshi
    Williams, Paul D.
    Cho, Kathleen R.
    Rhodes, Daniel R.
    Tomlins, Scott A.
    CANCER RESEARCH, 2015, 75 (24) : 5219 - 5227
  • [32] Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma
    Gao, Xin
    Jegede, Opeyemi
    Gray, Connor
    Catalano, Paul J.
    Novak, Jesse
    Kwiatkowski, David J.
    Mckay, Rana R.
    George, Daniel J.
    Choueiri, Toni K.
    McDermott, David D.
    Signoretti, Sabina
    Bhatt, Rupal S.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 341 - 348
  • [33] Bone Metastatic Disease: Taking Aim at New Therapeutic Targets
    Coluzzi, F.
    Di Bussolo, E.
    Mandatori, I.
    Mattia, C.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (20) : 3093 - 3115
  • [34] Basal cell carcinoma with progression to metastatic neuroendocrine carcinoma
    Patel, Raj
    Adsay, Volkan
    Andea, Aleodor
    RARE TUMORS, 2010, 2 (01) : 23 - 26
  • [35] Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma
    Pezzicoli, Gaetano
    Ciciriello, Federica
    Musci, Vittoria
    Salonne, Francesco
    Ragno, Anna
    Rizzo, Mimma
    CURRENT ONCOLOGY, 2023, 30 (10) : 9276 - 9290
  • [36] miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
    White, N. M. A.
    Khella, H. W. Z.
    Grigull, J.
    Adzovic, S.
    Youssef, Y. M.
    Honey, R. J.
    Stewart, R.
    Pace, K. T.
    Bjarnason, G. A.
    Jewett, M. A. S.
    Evans, A. J.
    Gabril, M.
    Yousef, G. M.
    BRITISH JOURNAL OF CANCER, 2011, 105 (11) : 1741 - 1749
  • [37] Genomic Characterization of Prostatic Basal Cell Carcinoma
    Low, Jin-Yih
    Ko, Minjeong
    Hanaratty, Brian
    A. Patel, Radhika
    Bhamidipati, Akshay
    Heaphy, Christopher M.
    Gayar, Erolcan
    K. Lee, John
    Li, Shan
    De Marzo, Angelo M.
    Nelson, William G.
    Gupta, Anuj
    Yengnasubramanium, Srinivasa
    Ha, Gavin
    Epstein, Jonathan I.
    Haffner, Michael C.
    AMERICAN JOURNAL OF PATHOLOGY, 2023, 193 (01) : 4 - 10
  • [38] Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets
    Lau, David K.
    Mouradov, Dmitri
    Wasenang, Wiphawan
    Luk, Ian Y.
    Scott, Cameron M.
    Williams, David S.
    Yeung, Yvonne H.
    Limpaiboon, Temduang
    Iatropoulos, George F.
    Jenkins, Laura J.
    Reehorst, Camilla M.
    Chionh, Fiona
    Nikfarjam, Mehrdad
    Croagh, Daniel
    Dhillon, Amardeep S.
    Weickhardt, Andrew J.
    Muramatsu, Toshihide
    Saito, Yoshimasa
    Tebbutt, Niall C.
    Sieber, Oliver M.
    Mariadason, John M.
    ISCIENCE, 2019, 21 : 624 - +
  • [39] Chest wall resection and reconstruction for metastatic basal cell carcinoma
    Cunnick, GH
    Sayer, RE
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (02): : 189 - 190
  • [40] Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal Metastasis
    Elsnerova, Katerina
    Bartakova, Alena
    Tihlarik, Josef
    Bouda, Jiri
    Rob, Lukas
    Skapa, Petr
    Hruda, Martin
    Gut, Ivan
    Mohelnikova-Duchonova, Beatrice
    Soucek, Pavel
    Vaclavikova, Radka
    JOURNAL OF CANCER, 2017, 8 (17): : 3598 - 3606